SynthesisThe Cochrane database of systematic reviews2017

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).

Nobuyuki Horita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.